Knowledge on rare diseases and orphan drugs
COVID-19 & Rare diseases
Rare Diseases Resources for Refugees/Displaced Persons
Search for a rare disease
Acquired angioedema type 2
A type of acquired angioedema (AAE) characterized by acute edema in subcutaneous tissues, viscera and/or the upper airway.
ORPHA:100055
Classification level: Subtype of disorder
- AAE 2
- AAE II
- Acquired angioneurotic edema type 2
Prevalence: -
Inheritance: Not applicable
Age of onset: Adult
Prevalence is unknown.
Like other forms of AAE, it has a later onset than HAE and occurs generally in adults over the age of 50 and there is no family history of the disease.
The disease occurs due to an acquired C1-INH deficiency caused by malfunctioning B cells that secrete autoantibodies to the C1-INH molecule that neutralize C1-INH activity. AAE type 2 is often associated with dysglobulinemia of unknown origin.
The treatments used for HAE can be effective for AAE but the most effective strategy is to decrease C1-INH antibody level with corticosteroids or rituximab.
Last update: August 2011 - Expert reviewer(s): Pr Laurence BOUILLET
: produced/endorsed by ERN(s)
: produced/endorsed by FSMR(s)
Guidelines
Further information on this disease
Patient-centred resources for this disease
Research activities on this disease
Newborn screening